Search Results - "Özcan, Gülnihal"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    SCUBE2 as a Marker of Resistance to Taxane-based Neoadjuvant Chemotherapy and a Potential Therapeutic Target in Breast Cancer by Özcan, Gülnihal

    Published in European journal of breast health (01-01-2023)
    “…Taxane-based neoadjuvant chemotherapy is the most common neoadjuvant approach in breast cancer, especially in human epidermal growth factor receptor 2…”
    Get full text
    Journal Article
  2. 2

    Extracranial transport of brain lymphatics via cranial nerve in human by Çavdar, Safiye, Altınöz, Damlasu, Dilan Demir, Tevriz, Ali Gürses, İlke, Özcan, Gülnihal

    Published in Neuroscience letters (28-03-2024)
    “…[Display omitted] Extracranial waste transport from the brain interstitial fluid to the deep cervical lymph node (dCLN) is not extensively understood. The…”
    Get full text
    Journal Article
  3. 3

    Brain lymphatic vessels accompanying meningeal arteries in the human by Çavdar, Safiye, Altınöz, Damlasu, Demir, Tevriz Dilan, Bayraktaroğlu, Acar, Gürses, İlke Ali, Özcan, Gülnihal

    Published in Translational research in anatomy (01-11-2024)
    “…Recent studies showed the connection between cerebrospinal fluid (CSF) and deep cervical lymph nodes (dCLN) via lymphatic vessels (LV)s. These LVs accompany…”
    Get full text
    Journal Article
  4. 4

    Cell Contact-dependent Functional Selectivity of β2-Adrenergic Receptor Ligands in Stimulating cAMP Accumulation and Extracellular Signal-regulated Kinase Phosphorylation by Kaya, Ali I., Onaran, H. Ongun, Özcan, Gülnihal, Ambrosio, Caterina, Costa, Tommaso, Balli, Sezen, Uğur, Özlem

    Published in The Journal of biological chemistry (24-02-2012)
    “…Activation of β2-adrenegic receptor (β2-AR) leads to an increase in intracellular cAMP and activation of ERK. These two signals are activated by the…”
    Get full text
    Journal Article
  5. 5
  6. 6

    PTCH1 and CTNNB1 emerge as pivotal predictors of resistance to neoadjuvant chemotherapy in ER+/HER2- breast cancer by Ozcan, Gulnihal

    Published in Frontiers in oncology (28-08-2023)
    “…Endeavors in the molecular characterization of breast cancer opened the doors to endocrine therapies in ER+/HER2- breast cancer, increasing response rates…”
    Get full text
    Journal Article
  7. 7

    Comprehensive bioinformatic analysis reveals a cancer-associated fibroblast gene signature as a poor prognostic factor and potential therapeutic target in gastric cancer by Ucaryilmaz Metin, Cemre, Ozcan, Gulnihal

    Published in BMC cancer (23-06-2022)
    “…Abstract Background Gastric cancer is one of the deadliest cancers, currently available therapies have limited success. Cancer-associated fibroblasts (CAFs)…”
    Get full text
    Journal Article
  8. 8

    The hypoxia-inducible factor-1α in stemness and resistance to chemotherapy in gastric cancer: Future directions for therapeutic targeting by Ozcan, Gulnihal

    “…Hypoxia-inducible factor-1α (HIF-1α) is a crucial mediator of intra-tumoral heterogeneity, tumor progression, and unresponsiveness to therapy in tumors with…”
    Get full text
    Journal Article
  9. 9

    Functional genomics reveals an off-target dependency of drug synergy in gastric cancer therapy by Leylek, Ozen, Honeywell, Megan E., Lee, Michael J., Hemann, Michael T., Ozcan, Gulnihal

    “…Background Integrating molecular-targeted agents into combination chemotherapy is transformative for enhancing treatment outcomes in cancer. However, realizing…”
    Get full text
    Journal Article
  10. 10

    Cancer-associated fibroblasts: protagonists of the tumor microenvironment in gastric cancer by Ozmen, Ece, Demir, Tevriz Dilan, Ozcan, Gulnihal

    Published in Frontiers in molecular biosciences (18-03-2024)
    “…Enhanced knowledge of the interaction of cancer cells with their environment elucidated the critical role of tumor microenvironment in tumor progression and…”
    Get full text
    Journal Article
  11. 11

    β 2-Adrenoceptor, Gs and adenylate cyclase coupling in purified detergent-resistant, low density membrane fractions by Öner, Ş. Sadık, Kaya, Ali İ., Onaran, H. Ongun, Özcan, Gülnihal, Uğur, Özlem

    Published in European journal of pharmacology (2010)
    “…Membrane rafts and caveolae are specialized microdomains of the cell membrane that form physical platforms for compartmentalization of signalling molecules…”
    Get full text
    Journal Article
  12. 12

    Abstract P023: Achieving synergism in combination chemotherapy for gastric cancer treatment by Leylek, Ozen, Ozcan, Gulnihal

    Published in Molecular cancer therapeutics (01-12-2021)
    “…Abstract Gastric cancer (GC) is the fifth most common cancer and the fourth leading cause of deaths from cancer. Although the combination of conventional…”
    Get full text
    Journal Article
  13. 13

    HEK-293 kültür hücrelerinde beta2-adrenerjik reseptör ligandlarının Camp ve erk yanıtları bakımından hücre kontaktına bağlı koşullu fonksiyonel seçiciliği by Özcan, Gülnihal

    Published 01-01-2011
    “…G proteinlerine kenetli reseptörler (GPKR'ler), hücre dışı sinyallerin hücre içine iletilmesini sağlayan hücre yüzeyi reseptörlerinin en büyük ailesidir…”
    Get full text
    Dissertation
  14. 14

    Preclinical and clinical development of siRNA-based therapeutics by Ozcan, Gulnihal, Ozpolat, Bulent, Coleman, Robert L., Sood, Anil K., Lopez-Berestein, Gabriel

    Published in Advanced drug delivery reviews (29-06-2015)
    “…The discovery of RNA interference, first in plants and Caenorhabditis elegans and later in mammalian cells, led to the emergence of a transformative view in…”
    Get full text
    Journal Article
  15. 15

    The HIF-1α as a Potent Inducer of the Hallmarks in Gastric Cancer by Ucaryilmaz Metin, Cemre, Ozcan, Gulnihal

    Published in Cancers (30-05-2022)
    “…Hypoxia is the principal architect of the topographic heterogeneity in tumors. Hypoxia-inducible factor-1α (HIF-1α) reinforces all hallmarks of cancer and…”
    Get full text
    Journal Article
  16. 16

    Resorufin Enters the Photodynamic Therapy Arena: A Monoamine Oxidase Activatable Agent for Selective Cytotoxicity by Almammadov, Toghrul, Atakan, Gizem, Leylek, Ozen, Ozcan, Gulnihal, Gunbas, Gorkem, Kolemen, Safacan

    Published in ACS medicinal chemistry letters (10-12-2020)
    “…A red-absorbing, water-soluble, and iodinated resorufin derivative (R1) that can be selectively activated with a monoamine oxidase (MAO) enzyme was…”
    Get full text
    Journal Article
  17. 17

    beta2-Adrenoceptor, Gs and adenylate cyclase coupling in purified detergent-resistant, low density membrane fractions by Oner, S Sadik, Kaya, Ali I, Onaran, H Ongun, Ozcan, Gülnihal, Uğur, Ozlem

    Published in European journal of pharmacology (25-03-2010)
    “…Membrane rafts and caveolae are specialized microdomains of the cell membrane that form physical platforms for compartmentalization of signalling molecules…”
    Get full text
    Journal Article
  18. 18

    Adverse Drug Reaction Reporting Pattern in Turkey: Analysis of the National Database in the Context of the First Pharmacovigilance Legislation by Ozcan, Gulnihal, Aykac, Emel, Kasap, Yelda, Nemutlu, Nergiz T., Sen, Ebru, Aydinkarahaliloglu, N. Demet

    Published in Drugs -- real world outcomes (01-03-2016)
    “…Introduction In Turkey, pharmacovigilance began in 1985. A fully structured adverse drug reaction (ADR)-reporting system was established with the publication…”
    Get full text
    Journal Article
  19. 19

    Various Phosphodiesterase Activities in Different Regions of the Heart Alter the Cardiac Effects of Nitric Oxide by Demirel-Yilmaz, Emine, Cenik, Basar, Ozcan, Gulnihal, Derici, Mehmet Kursat

    Published in Journal of cardiovascular pharmacology (01-09-2012)
    “…The modulation of cardiac functions by nitric oxide (NO) was established. This study examined the influences of phosphodiesterase (PDE) inhibitors on the…”
    Get full text
    Journal Article
  20. 20